Doxorubicin Eluting Intra-arterial Embolization for Aggressive Desmoid Fibromatosis

Clinical trial NCT03966742 · COMPLETED

Trial details

NCT number: NCT03966742
Sponsor: Rabin Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Desmoid Desmoid Fibromatosis of Skin Desmoid Neoplasm of Chest Wall Desmoid Tumor Caused by Somatic Mutation Aggressive Fibromatoses Fibromatosis Desmoid Desmoid Fibromatosis

Start date: 2018-10-11
Primary completion: 2020-12-18
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.